Gossamer Bio, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Gossamer Bio, Inc. reported Cash And Cash Equivalents At Carrying Value of $37.73 million for the year ending 2025.

  • Gossamer Bio, Inc. showed a decrease of -18.1% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Gossamer Bio, Inc.'s annual report (Form 10-K), filed with the SEC on March 17, 2026.
  • XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 8 years of available data (2018 to 2025), Gossamer Bio, Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 64.1%.
  • Historical annual values: Fiscal year 2025: $37.73 million | Fiscal year 2024: $46.07 million | Fiscal year 2023: $32.11 million | Fiscal year 2022: $111.97 million | Fiscal year 2021: $183.40 million | Fiscal year 2020: $486.06 million | Fiscal year 2019: $135.03 million | Fiscal year 2018: $105.22 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: